Clinical trial
Tofacitinib Use in Rituximab-Experienced RA Patients
NCT05487703 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tofacitinib Use in Rituximab-Experienced RA Patients
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 14, 2022
- Completion date
- December 23, 2022
- Enrollment
- 318 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.